Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) is now available.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced a special cash dividend of HKD 1.5 per share, with shareholders’ approval set for July 21, 2025. This announcement may impact the company’s financial distribution strategy and provide returns to shareholders, reflecting the company’s current financial health and commitment to shareholder value.
The most recent analyst rating on (HK:1558) stock is a Buy with a HK$13.80 price target. To see the full list of analyst forecasts on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H stock, see the HK:1558 Stock Forecast page.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Hong Kong Stock Exchange and is involved in producing a range of medical products.
Average Trading Volume: 9,690,048
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.11B
Learn more about 1558 stock on TipRanks’ Stock Analysis page.